RNA, U1 small nuclear 108, pseudogene (RNU1-108P)

RNU1-108P is classified as a **pseudogene** of the U1 small nuclear RNA family. Pseudogenes are nonfunctional DNA segments that closely resemble known genes but typically lack protein-coding potential or usual biological activity[4]. In the case of U1 snRNA pseudogenes—including RNU1-108P—they are derived from or highly similar to the canonical U1 small nuclear RNA gene, a component of the **spliceosome** involved in pre-mRNA splicing[1][3]. While canonical U1 snRNA genes are essential for gene expression regulation and transcriptome integrity, pseudogenes like RNU1-108P are generally not considered functional, although emerging research suggests some pseudogenes may be transcribed and could exert regulatory effects in rare cases[3][4]. However, there is no evidence that RNU1-108P itself encodes a functional molecule, serves as a therapeutic target, or has clinical relevance as a biomarker or drug target. It is also not a receptor, enzyme, transporter, or similar therapeutic entity[3][4]. **Summary of rationale for key decisions:** - **is_target:** false — RNU1-108P is a pseudogene and not a validated or recognized therapeutic target. - **is_incorrect:** true — The target is not functional or actionable for therapeutic development and lacks specific biological or clinical roles. This is not a receptor, enzyme, transporter, or disease-linked molecule. - **molecular_classifications:** Classified under "Other" to signify its nature as a non-coding RNA pseudogene, not belonging to standard therapeutic target classes. - **disease_roles/biomarkers:** No evidence for clinical association or biomarker role specific to RNU1-108P; general pseudogene roles in cancer or other diseases noted in broad literature but not for this specific pseudogene[2][3].

Other names

RNU1-108PRNA, U1 small nuclear 108, pseudogene